These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27960080)

  • 1. A Novel Link between Inflammation and Cancer.
    Grinberg-Bleyer Y; Ghosh S
    Cancer Cell; 2016 Dec; 30(6):829-830. PubMed ID: 27960080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
    Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
    Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
    Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
    Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitination and Stabilization of PD-L1 by CSN5.
    Lim SO; Li CW; Xia W; Cha JH; Chan LC; Wu Y; Chang SS; Lin WC; Hsu JM; Hsu YH; Kim T; Chang WC; Hsu JL; Yamaguchi H; Ding Q; Wang Y; Yang Y; Chen CH; Sahin AA; Yu D; Hortobagyi GN; Hung MC
    Cancer Cell; 2016 Dec; 30(6):925-939. PubMed ID: 27866850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells.
    Wang Y; Sun Q; Mu N; Sun X; Wang Y; Fan S; Su L; Liu X
    Cell Commun Signal; 2020 Jul; 18(1):112. PubMed ID: 32665011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
    Zhong G; Li H; Shan T; Zhang N
    Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1.
    Ma Y; Xia P; Wang Z; Xu J; Zhang L; Jiang Y
    Neoplasia; 2021 Sep; 23(9):912-928. PubMed ID: 34325342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial CSN5 impairs NF-κB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions.
    Asare Y; Shagdarsuren E; Schmid JA; Tilstam PV; Grommes J; El Bounkari O; Schütz AK; Weber C; de Winther MP; Noels H; Bernhagen J
    Thromb Haemost; 2013 Jul; 110(1):141-52. PubMed ID: 23636414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of PD-L1 Expression by NF-κB in Cancer.
    Antonangeli F; Natalini A; Garassino MC; Sica A; Santoni A; Di Rosa F
    Front Immunol; 2020; 11():584626. PubMed ID: 33324403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
    Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
    Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer.
    Pan Y; Yang H; Claret FX
    Cancer Biol Ther; 2014 Mar; 15(3):256-62. PubMed ID: 24495954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant homologue constitutive photomorphogenesis 9 (COP9) signalosome subunit CSN5 regulates innate immune responses in macrophages.
    Deng Z; Pardi R; Cheadle W; Xiang X; Zhang S; Shah SV; Grizzle W; Miller D; Mountz J; Zhang HG
    Blood; 2011 May; 117(18):4796-804. PubMed ID: 21403132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.
    Adler AS; Littlepage LE; Lin M; Kawahara TL; Wong DJ; Werb Z; Chang HY
    Cancer Res; 2008 Jan; 68(2):506-15. PubMed ID: 18199546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB and Its Role in Checkpoint Control.
    Betzler AC; Theodoraki MN; Schuler PJ; Döscher J; Laban S; Hoffmann TK; Brunner C
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB.
    Xue J; Chen C; Qi M; Huang Y; Wang L; Gao Y; Dong H; Ling K
    Oncotarget; 2017 Jun; 8(26):42414-42427. PubMed ID: 28465490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovering New Metallo-Deubiquitinase CSN5 Inhibitors by a Non-Catalytic Activity Assay Platform.
    Yan YH; Wei LL; Wu JW; Wei SQ; Jiang YY; Yu JL; Yang LL; Li GB
    J Med Chem; 2024 Aug; 67(16):14649-14667. PubMed ID: 39129245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer.
    Guo Z; Wang Y; Zhao Y; Shu Y; Liu Z; Zhou H; Wang H; Zhang W
    Gene; 2019 Mar; 687():219-227. PubMed ID: 30468907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of RNA expression of normal and cancer tissues reveals high correlation of COP9 gene expression with respiratory chain complex components.
    Wicker CA; Izumi T
    BMC Genomics; 2016 Dec; 17(1):983. PubMed ID: 27903243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of NF-kappaB activation by the COP9 signalosome.
    Schweitzer K; Naumann M
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):156-61. PubMed ID: 20074051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune regulation of canine tumour and macrophage PD-L1 expression.
    Hartley G; Faulhaber E; Caldwell A; Coy J; Kurihara J; Guth A; Regan D; Dow S
    Vet Comp Oncol; 2017 Jun; 15(2):534-549. PubMed ID: 26842912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.